INS and steatosis: Inhibiting serine palmitoyltransferase, the initial rate-limiting step in sphingolipid synthesis, with myriocin lowered ceramide levels, improved glucose tolerance, increased insulin sensitivity, and decreased hepatic steatosis in diabetic rodent models [16], [18].